Intelligent Bio Solutions (INBS.US): The 2024 Q3 earnings report achieved revenue of US$823,800, with a previous value of US$457.06 million and an expected value of US$1.08 million; earnings per share were -1.43 dollars, previous value of -68.64 dollars, and expected value of -2.52 dollars.
Intelligent Bio Solutions(INBS.US)：2024年Q3财报实现营收82.38万美元，前值为45.706万美元，预期值为108万美元；每股收益为-1.43美元，前值为-68.64美元，预期值为-2.52美元。
Intelligent Bio Solutions (INBS.US): The 2024 Q3 earnings report achieved revenue of US$823,800, with a previous value of US$457.06 million and an expected value of US$1.08 million; earnings per share were -1.43 dollars, previous value of -68.64 dollars,
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.